food for thought. I ran across these two articles today in the Times and the Wall Street Journal so I thought they might be of some interest here given some of the other threads related to the FDA and China.

The WSJ article concerns the FDA and it's inability to really effectively police the Chindia (the latest new reference for China and India) imports for the US pharmaceutical industry.

The long Times article deals specifically with the problems in the Chinese pharmaceutical industry and why the situation is grave now and will probably only get worse with time.

FDA oversight of Chinese API manufacturers
http://online.wsj.com/article/SB119379873952277258.html

Chinese API manufacturers
http://www.nytimes.com/2007/10/31/wo...hp&oref=slogin

Sorry to be such a downer here.

Alkymst